2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T5693,

Summary Table

Category	Details
Risk Factors	Sexually active women of reproductive age, multiple sexual partners, douching, lack of vaginal lactobacilli, new sexual partner, IUD use, African American ethnicity (higher prevalence)
Etiology	Polymicrobial overgrowth of anaerobes (primarily Gardnerella vaginalis, Prevotella, Mobiluncus, Mycoplasma hominis, Atopobium vaginae) replacing normal Lactobacillus-dominant flora
Patient Presentation	Thin, grayish-white vaginal discharge with a fishy odor, often worse after intercourse or during menses; notably not associated with pruritus, dysuria, or dyspareunia
Classic Physical Exam	Homogeneous, thin, milky discharge coating the vaginal walls; no vulvar or vaginal erythema, no cervical inflammation
Key Diagnostic Results	Vaginal pH > 4.5, positive whiff test (amine/fishy odor with KOH), clue cells on wet mount, absence of lactobacilli on Gram stain (Nugent score 7 or above)
Management	Metronidazole 500 mg orally twice daily for 7 days (first-line); alternatives include metronidazole vaginal gel or clindamycin vaginal cream
Keywords	"Fishy odor," "clue cells," "thin grayish discharge," "pH > 4.5," "positive whiff test," "no pruritus," "Gardnerella"

1. Pathophysiology

Bacterial vaginosis (BV) is fundamentally a disruption of the normal vaginal microbiome. Under healthy conditions, the vaginal flora is dominated by hydrogen peroxide-producing Lactobacillus species (primarily L. crispatus and L. jensenii). These organisms maintain vaginal pH between 3.8 and 4.5, creating an acidic environment that suppresses the growth of pathogenic and opportunistic anaerobes.

In BV, there is a dramatic shift from Lactobacillus dominance to a polymicrobial anaerobic overgrowth. Gardnerella vaginalis serves as the initial colonizer, forming a dense biofilm on the vaginal epithelium. This biofilm provides a scaffold for other anaerobes such as Prevotella, Mobiluncus, and Atopobium vaginae to co-colonize and proliferate. The loss of lactobacilli removes the protective acid barrier, allowing vaginal pH to rise above 4.5.

The anaerobic bacteria produce amino acid decarboxylases, enzymes that break down peptides and proteins into volatile amines, specifically trimethylamine and putrescine. These amines are responsible for the characteristic fishy odor. The odor becomes more pronounced when the discharge is exposed to alkaline conditions, which is why it intensifies after unprotected intercourse (semen is alkaline, pH around 7.2) and during menses (blood is alkaline relative to vaginal pH). This is the biochemical basis of the positive whiff test when potassium hydroxide (KOH) is added to the discharge.

Clue cells, the hallmark microscopic finding, are vaginal squamous epithelial cells whose surfaces are so densely coated with adherent bacteria (predominantly Gardnerella and anaerobes) that their borders become obscured and stippled. The cell edges appear granular rather than sharply defined. This finding directly reflects the biofilm-forming nature of the causative organisms.

Critically, BV is not a true infection in the inflammatory sense. There is no significant host inflammatory response, which is why the vaginal mucosa shows no erythema, no edema, and no pain. The white blood cell count on wet mount is characteristically low. This distinguishes BV from true vaginitis caused by Trichomonas or Candida, where inflammation is prominent.

BV during pregnancy carries clinical significance because the ascending anaerobic organisms can cause chorioamnionitis, preterm premature rupture of membranes, and preterm labor. It is also associated with increased susceptibility to sexually transmitted infections, including HIV, gonorrhea, chlamydia, and herpes simplex virus, due to the loss of the protective Lactobacillus barrier and alteration of local immune defenses.

2. Classification and Clinical Manifestation

Diagnostic Classification (Nugent Scoring System)

Nugent Score	Interpretation	Microscopic Findings
0 to 3	Normal flora	Predominance of large Gram-positive rods (Lactobacillus morphotypes)
4 to 6	Intermediate flora	Mixed flora with reduced lactobacilli and some Gram-variable or Gram-negative rods
7 to 10	Bacterial vaginosis	Few or absent lactobacilli, predominance of Gardnerella morphotypes (small Gram-variable rods) and Mobiluncus morphotypes (curved Gram-negative rods)

Clinical Presentation

Presentation	Features	Exam Relevance
Symptomatic BV	Fishy-smelling thin grayish-white discharge, worse after intercourse or menses; no itch, no pain	The classic vignette presentation
Asymptomatic BV	No symptoms; diagnosed incidentally on Gram stain or during prenatal screening	Important in pregnancy, where treatment is indicated even without symptoms in women with history of preterm birth
Recurrent BV	Three or more documented episodes within 12 months	May require suppressive therapy with metronidazole gel twice weekly for 4 to 6 months

3. Diagnostic Workup

Diagnostic Summary Table

Test	Role	Key Finding
Amsel Criteria (clinical)	Best initial diagnostic method in office setting	Need 3 of 4 criteria positive
Nugent Score (Gram stain)	Gold standard / most accurate test	Score 7 to 10 confirms BV
Vaginal pH	Component of Amsel criteria	> 4.5 (normally 3.8 to 4.5)
Whiff test (KOH)	Component of Amsel criteria	Fishy (amine) odor when KOH added
Wet mount microscopy	Component of Amsel criteria	Clue cells in at least 20% of epithelial cells
Discharge character	Component of Amsel criteria	Thin, homogeneous, grayish-white
NAAT / molecular testing	Emerging point-of-care option	Detects Gardnerella, BVAB-2, Atopobium vaginae, Megasphaera type 1

The best initial diagnostic approach in clinical practice is the Amsel criteria, which can be performed at the bedside during a pelvic examination. A diagnosis of BV requires at least 3 of the following 4 criteria:

Thin, homogeneous, grayish-white discharge that smoothly coats the vaginal walls
Vaginal pH greater than 4.5, measured by touching pH paper to the vaginal sidewall (not the cervix, which has a naturally higher pH and would give a false reading)
Positive whiff test: a fishy odor released when 10% potassium hydroxide (KOH) is added to a sample of the discharge, caused by volatilization of amines
Clue cells on saline wet mount, comprising at least 20% of the epithelial cells observed

The most accurate (gold standard) test is the Nugent score, a standardized Gram stain scoring system that quantifies Lactobacillus, Gardnerella, and Mobiluncus morphotypes on a 0 to 10 scale. A score of 7 or above confirms BV. This test is primarily used in research settings and reference laboratories because it requires trained microscopists. For exam purposes, recognize Nugent scoring as the confirmatory test when the question stem asks for the "most accurate" method.

An important exam pearl: cultures for Gardnerella vaginalis are NOT useful for diagnosing BV. Gardnerella can be found as a commensal in up to 50 to 60% of healthy women without BV. A positive culture does not distinguish colonization from disease and should never be ordered.

Molecular/NAAT-based point-of-care tests (e.g., BD MAX BV Panel, Aptima BV) are increasingly available and detect nucleic acids of BV-associated organisms. These are highly sensitive and are used in settings where microscopy is not available.

A finding that is notably absent in BV and helps distinguish it microscopically: white blood cells are NOT elevated on wet mount. If the wet mount shows abundant neutrophils, consider Trichomonas vaginalis or cervicitis from gonorrhea/chlamydia rather than BV.

4. Management and Treatment

Setting	Regimen	Details
First-line (non-pregnant)	Metronidazole 500 mg PO BID x 7 days	Cure rate approximately 80 to 90%; most tested regimen
Alternative oral	Tinidazole 2 g PO once daily x 2 days, OR Tinidazole 1 g PO once daily x 5 days	Better GI tolerability than metronidazole
Alternative topical	Metronidazole gel 0.75%, one applicator (5 g) intravaginally once daily x 5 days	Equivalent efficacy to oral; fewer systemic side effects
Alternative topical	Clindamycin cream 2%, one applicator (5 g) intravaginally at bedtime x 7 days	Use when metronidazole is contraindicated or not tolerated
Alternative oral	Clindamycin 300 mg PO BID x 7 days	Second-line oral option
Pregnant (symptomatic)	Metronidazole 500 mg PO BID x 7 days OR Metronidazole 250 mg PO TID x 7 days	Safe in all trimesters; old concern about first-trimester teratogenicity has been disproven
Recurrent BV	Suppressive: Metronidazole gel 0.75% intravaginally twice weekly x 4 to 6 months after initial treatment course	Reduces recurrence rate from approximately 50% to around 30%

Detailed Management

Acute treatment centers on metronidazole 500 mg orally twice daily for 7 days, which remains the most studied and most frequently tested regimen. Patients must be counseled to avoid alcohol during treatment and for 48 hours after completion due to a disulfiram-like reaction (nausea, vomiting, flushing, headache). This is a high-yield exam point: the question may describe a patient on metronidazole who develops flushing and vomiting after drinking alcohol.

Tinidazole is a second-generation nitroimidazole with a longer half-life and improved GI tolerability compared to metronidazole. It can be given as a shorter course (2 g daily for 2 days) but is more expensive.

Intravaginal clindamycin cream is an effective alternative but carries an important caveat: it is oil-based and can weaken latex condoms and diaphragms for up to 5 days after use. This must be disclosed to the patient.

Treatment of sexual partners is NOT recommended. Multiple randomized controlled trials have shown that treating male sexual partners does not reduce recurrence rates in women. BV is not classified as a sexually transmitted infection, though sexual activity is a risk factor. This is a commonly tested point: the question may offer partner treatment as an answer choice, and it is incorrect.

Asymptomatic BV generally does not require treatment in non-pregnant women. However, treatment is recommended before gynecologic surgical procedures (hysterectomy, endometrial biopsy, IUD insertion, abortion) to reduce the risk of postoperative infectious complications.

In pregnancy, treatment of symptomatic BV is recommended to alleviate symptoms and reduce obstetric complications. Screening and treatment of asymptomatic BV in pregnant women is currently recommended only for those with a prior history of preterm birth. Oral metronidazole is preferred over intravaginal preparations in pregnancy because systemic treatment more effectively reaches the upper genital tract where ascending infection causes complications.

Recurrent BV (three or more episodes per year) is common, with recurrence rates approaching 50% within 12 months of treatment. After completing a standard treatment course, suppressive therapy with metronidazole vaginal gel twice weekly for 4 to 6 months has been shown to reduce recurrence.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Is Similar	Key Discriminator
Trichomonas vaginalis	Both cause vaginal discharge with elevated pH (> 4.5) and a possible positive whiff test	Trichomonas causes yellow-green frothy discharge with vulvovaginal erythema, pruritus, and strawberry cervix; wet mount shows motile flagellated trichomonads and abundant WBCs, not clue cells
Vulvovaginal candidiasis	Both cause vaginal discharge in reproductive-age women	Candida causes thick, white, cottage-cheese discharge with intense pruritus and vulvar erythema; vaginal pH is normal (< 4.5); KOH prep shows pseudohyphae and budding yeast, not clue cells
Cervicitis (Gonorrhea/Chlamydia)	Can cause vaginal discharge	Cervicitis presents with mucopurulent cervical discharge, cervical motion tenderness, and friable cervix; BV has no cervical involvement; NAAT confirms the STI
Desquamative inflammatory vaginitis	Causes a purulent vaginal discharge with elevated pH	Shows diffuse vaginal erythema with abundant parabasal cells and WBCs on wet mount; clue cells are absent; responds to topical clindamycin or hydrocortisone
Atrophic vaginitis	Common in postmenopausal women with elevated vaginal pH and discharge	Thin, pale vaginal mucosa with petechiae and loss of rugae; wet mount shows parabasal cells and reduced lactobacilli but no clue cells; responds to topical estrogen
Physiologic discharge	Normal discharge that varies with menstrual cycle	Clear to white, non-odorous, pH < 4.5, no clue cells, no whiff test positivity

6. Traps and High-Yield Pearls

The most common way students lose points on BV questions is by confusing BV with Trichomonas vaginalis. Both conditions elevate vaginal pH above 4.5 and can produce a positive whiff test. The critical differentiator the test-writer embeds in the stem is the presence or absence of inflammation: BV is a non-inflammatory condition (no erythema, no pruritus, no WBCs on wet mount), while Trichomonas triggers a brisk inflammatory response. If the vignette describes pruritus, erythema, or a frothy greenish discharge, it is not BV regardless of the pH.

A second trap involves ordering a vaginal culture for Gardnerella. The test-writer may include this as a tempting answer choice, but it is never correct because Gardnerella is a normal commensal in many women. The correct diagnostic approach is Amsel criteria (bedside) or Nugent scoring (laboratory).

Students also err by recommending treatment of the male sexual partner. Unlike Trichomonas or Chlamydia, there is no evidence that partner treatment improves outcomes in BV. If the question asks for the next step after diagnosing BV, the answer is treating the patient alone.

Another tested concept is the metronidazole-alcohol interaction. A vignette describing nausea, vomiting, and facial flushing in a woman recently started on metronidazole who attended a social event is testing your knowledge of the disulfiram-like reaction.

Finally, recognize that BV in pregnancy is linked to preterm labor and premature rupture of membranes. If a pregnant woman presents with preterm contractions and a workup reveals BV, the question is testing whether you know to treat with oral metronidazole (safe in pregnancy, including the first trimester) and that intravaginal therapy is less preferred in pregnancy because it does not adequately treat the upper genital tract.

The core competency being tested across BV questions is pattern recognition of a non-inflammatory vaginal condition (no itch, no redness, no pain) with a characteristic fishy odor and clue cells, and the ability to distinguish this presentation from inflammatory causes of vaginitis.

1e:["$","$L2d",null,{"article":{"id":"dc0872ee-57a0-4188-8f94-48c4f42e78e9","title":"Vaginosis Bakterialis","content":"$2e","category":"Reproduksi","created_at":"2026-05-16T10:24:51.545986+00:00","status":"published","subcategory":null},"questionCount":2,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]